SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+10.94%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$382M
AUM Growth
+$382M
(-5.7%)
Cap. Flow
-$40.1M
Cap. Flow
% of AUM
-10.48%
Top 10 Holdings %
Top 10 Hldgs %
34.79%
Holding
131
New
16
Increased
23
Reduced
53
Closed
27
Top Buys
| 1 |
Tower Semiconductor
TSEM
|
$8.81M |
| 2 |
Biogen
BIIB
|
$7.54M |
| 3 |
Forte Biosciences
FBRX
|
$6.4M |
| 4 |
Cytokinetics
CYTK
|
$6.01M |
| 5 |
Cidara Therapeutics
CDTX
|
$5.89M |
Top Sells
| 1 |
BridgeBio Pharma
BBIO
|
$12.1M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$6.08M |
| 3 |
Nice
NICE
|
$5.13M |
| 4 |
Merus
MRUS
|
$4.48M |
| 5 |
Sanofi
SNY
|
$4.11M |
Sector Composition
| 1 | Healthcare | 73.22% |
| 2 | Technology | 19.05% |
| 3 | Consumer Discretionary | 1.86% |
| 4 | Utilities | 1.71% |
| 5 | Communication Services | 1.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
WIX.com
WIX
$8.05B
| $2.68M | 0.63% |
16,931
+8,131
| +92% | +$1.29M |
|
52
Amgen
AMGN
$153B
| $2.65M | 0.62% |
9,500
-500
| -5% | -$140K |
|
53
SolarEdge
SEDG
$1.97B
| $2.61M | 0.61% |
127,966
-181,250
| -59% | -$3.7M |
|
54
Enliven Therapeutics
ELVN
$1.24B
| $2.58M | 0.61% |
128,515
+16,772
| +15% | +$336K |
|
55
Skye Bioscience
SKYE
$104M
| $2.25M | 0.53% |
538,434
-937,919
| -64% | -$3.92M |
|
56
Dyne Therapeutics
DYN
$1.92B
| $2.11M | 0.49% |
221,416
-107,846
| -33% | -$1.03M |
|
57
Pfizer
PFE
$141B
| $2.08M | 0.49% |
86,000
-4,000
| -4% | -$97K |
|
58
Biohaven
BHVN
$1.71B
| $2.05M | 0.48% |
145,372
+45,588
| +46% | +$643K |
|
59
Scholar Rock
SRRK
$3.3B
| $2.04M | 0.48% |
57,497
-20,696
| -26% | -$733K |
|
60
89bio
ETNB
$1.37B
| $2.02M | 0.47% |
205,675
-412,668
| -67% | -$4.05M |
|
61
Structure Therapeutics
GPCR
$1.14B
| $1.99M | 0.47% |
95,931
+11,931
| +14% | +$247K |
|
62
Janux Therapeutics
JANX
$1.38B
| $1.98M | 0.47% |
85,840
-40,000
| -32% | -$924K |
|
63
Apellis Pharmaceuticals
APLS
$3.51B
| $1.98M | 0.46% |
114,346
-67,000
| -37% | -$1.16M |
|
64
Salesforce
CRM
$245B
| $1.85M | 0.44% |
6,800
-2,300
| -25% | -$627K |
|
65
enGene Holdings
ENGN
$249M
| $1.84M | 0.43% |
504,409
-23,956
| -5% | -$87.2K |
|
66
CyberArk
CYBR
$23B
| $1.63M | 0.38% |
+4,000
| New | +$1.63M |
|
67
Marvell Technology
MRVL
$53.7B
| $1.45M | 0.34% |
18,730
+3,660
| +24% | +$283K |
|
68
Astria Therapeutics
ATXS
$394M
| $1.38M | 0.32% |
257,402
+67,602
| +36% | +$362K |
|
69
Kura Oncology
KURA
$732M
| $1.36M | 0.32% |
235,522
-108,000
| -31% | -$623K |
|
70
iShares Bitcoin Trust
IBIT
$83.8B
| $1.31M | 0.31% |
21,455
+13,305
| +163% | +$814K |
|
71
Intellia Therapeutics
NTLA
$1.26B
| $1.21M | 0.28% |
128,780
-252,300
| -66% | -$2.37M |
|
72
Ventyx Biosciences
VTYX
$184M
| $1.19M | 0.28% |
555,814
-456,935
| -45% | -$978K |
|
73
Advanced Micro Devices
AMD
$263B
| $1.17M | 0.27% |
+8,250
| New | +$1.17M |
|
|
NNDM
74
Nano Dimension
NNDM
$296M
| $1.16M | 0.27% |
717,518
| – | – |
|
75
Day One Biopharmaceuticals
DAWN
$766M
| $1.14M | 0.27% |
175,371
-159,616
| -48% | -$1.04M |
|